About the Journal

1. Mission:

Due to the rapid growth of the field of RNA and its potential applications including RNA therapeutics, it is encouraging to have an RNA journal that advances the field by bridging the fundamental research and application of RNA. The prediction that RNA will become the third milestone in drug development has become a reality.  The establishment of an RNA journal related to this field by the International Society for RNA Nanotechnology and Nanomedicine (ISRNN) will be in line with the vision and mission of the society. 

2. The journal scope:

This journal will include both the fundamentals and application of RNA, paying special attention to bridge these two areas.  Fundamental include both the structure and function and RNA.  The application includes RNA nanotechnology and RNA therapeutics.  RNA therapeutics include both the RNA as drugs and drugs targeting RNA, as well as extracellular RNA communication, paying special attention to new technology and the development of RNA therapeutics as the third milestone in pharmaceutical drug development.

Areas of interest include (but are not limited to) the following:

1) Chemistry, physics, optics, biophysics, computation, and other nanotechnology with potential applications in RNA.

2) RNA as drugs: RNA nanoparticles, aptamers, siRNAs, miRNAs, riboswitches, ribozymes, and other small noncoding RNA, in vivo delivery, treatment of cancer and other diseases.

3) Drugs that bind RNA: screening and design of chemical drugs that bind and inhibit RNA function.

4) The mobility and dynamics of RNA in vitro and in vivo including its trafficking and biodistribution in the body: concepts, design, and characterization.

5) Interactions of RNA with other classes of biological molecules such as proteins, lipids, glucose, and immune systems.

6) RNA as nanomaterials, polymers. antibodies, biosensors.

7) Inter-RNA interaction, computational studies, and machine learning on RNA 2D, 3D and 4D structures and nanoparticle formation.

8) Discovery of new RNA including long and short noncoding RNA and their in vivo processing and regulation.

9) Extracellular vesicles (EV) and Exosomes (EX), including RNA-decorated-EV and EX, RNA isolation/identification in EX and EX, RNA delivery by EV and EX, use of EV or EX for therapy, diagnosis, and tissue/organ repair.

3.Editorial board: 

Editor in Chief:

Peixuan Guo; The Ohio State University, Columbus, OH, USA (More info)

Executive Editor:

Kirill A. Afonin; UNC Charlotte, NC, USA (More info)

Associate Editors (List alphabetically):

Bruce Shapiro; NCI, Frederick, MD (More info)

Daniel Binzel: The Ohio State University, Columbus, OH, USA (More info)

Emil Khisamutdinov, Ball State University, Muncie, IN, USA (More info)

Eric Westhof; University of Strasbourg, Germany (More info)

Shi-Jie Chen, University of Missouri, Columbia, MO, USA (More info)

Tushar Patel, Mayo Clinic,Jacksonville, FL, USA (More info)

Wayne Miles; The Ohio State University, Columbus, OH, USA (More info)

Xing-Jie Liang, National Center for Nanoscience and Technology, China (More info)

Zhe-Sheng Chen, St. John’s University, Queens, NY, USA (More info)

Editorial Board:

David Lilley, University of Dundee, Dundee, Scotland (More info)

David Gorenstein, AM Biotechnologies, LLC

Jong Bum Lee, University of Seoul, Seoul, South Korea (More info)

Hirohide Saito, Kyoto University, Kyoto, Japan (More info)

 Jørgen Kjems, AARHUS University, Aarhus, Denmark (More info)

Thomas Schmittgen, University of Florida, Gainesville, FL, USA (More info)

Nils Walter, University of Michigan, Ann Arbor, MI, USA (More info)

 Xiaoting Zhang, University of Cincinnati, Cincinnati, OH, USA (More info)

Yuri Lyubchenko, University of Nebraska, Lincoln, NE, USA (More info)

Mark Evers, University of Kentucky, Lexington, KY, USA (More info)

Thomas Hermann, University of California San Diego, La Jolla, CA, USA (More info)

Anil Sood, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (More info)

Carlo Croce, The Ohio State University, Columbus, OH, USA (More info)

Robert Batey, University of Colorado Boulder, Boulder, CO, USA (More info)

Luc Jaeger, University of California Santa Barbara, Santa Barbara, CA, USA (More info)

Mark Bathe, MIT, Cambridge, MA, USA (More info)

Ebbe Anderson, AARHUS University, Aarhus, Denmark (More info)

Arkadiusz Chworos, Polish Academy of Sciences, Lodz, Poland (More info)

John Rossi, City of Hope, Duarte, CA, USA (More info)

Yizhou Dong, Mount Sinai, New York, NY, USA (More info)

Xandra Breakefield, Harvard University, Charlestown, MA, USA (More info)

Marina Dobrovolskaia, NCI, Frederick, MD (More info)

Shyam Rele, U.S. Department of Health and Human Services, Washington, D.C., USA (More info)